3 upcoming ADO milestones that I am excited for:
- June 2021 Saliva use case CE Mark update (see 17 May ASX Ann). If this is as accurate as our nasal swap results, surely this will be in high demand. I hope path to commercialisation is improved if this is the case, given the use case for saliva.
- July - Sept (Q3) 2021: COVID-19 Flu A/B Multiplex Test Clinical trials (see p.10 Investor Presentation ASX Ann 28 April). If we sell this test to tackle the N Hemisphere flu season, it'll be a great Christmas for all.
- "Late 2021": Collaborator 8 + their battery component manufacturer customers conducting AnteoX trials (see 26 April ASX Ann), which has proven ~18% improvement in their anode’s specific capacity. If these trials prove equally successful, with our "very large northern Asian diversified electronics manufacturer", we may just have a nice little Christmas present
Moving forward, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.003(11.5%) |
Mkt cap ! $72.20M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.7¢ | 2.9¢ | $1.433M | 44.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 870964 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 511263 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |